Glimefest Trio 2mg/500mg/0.3mg Tablet
Marketer
Arkas Pharma Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimefest Trio 2mg/500mg/0.3mg Tablet
Glimefest Trio (2mg/500mg/0.3mg) tablets are classified as antidiabetic medications. This triple-combination drug treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a holistic approach, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms—sweating, dizziness, headache, tremors—and know how to manage them. Maintain regular mealtimes and always carry a readily available glucose source (e.g., sugary snacks, fruit juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are essential as directed by your healthcare provider.
Uses of Glimefest Trio 2mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Glimefest Trio 2mg/500mg/0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimefest Trio 2mg/500mg/0.3mg tablets on an empty stomach.
Common Side effects of Glimefest Trio 2mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimefest Trio 2mg/500mg/0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimefest Trio 2mg/500mg/0.3mg Tablets should be administered on an empty stomach.
How Glimefest Trio 2mg/500mg/0.3mg Tablet works:
Glimepiride, metformin, and pioglitazone, each at a respective dose of 2mg, 500mg, and 0.3mg, are formulated together in a single tablet known as Glimefest Trio.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimefest Trio 2mg/500mg/0.3mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Glimefest Trio 2mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimefest Trio 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glimefest Trio 2mg/500mg/0.3mg tablets is inadvisable for individuals with kidney impairment and should be avoided. Patients with severe kidney disease should definitely not use this medication. Medical advice is recommended.
LiverCAUTION
Patients with liver impairment should use Glimefest Trio 2mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is necessary. For those with mild to moderate liver disease, initiation should be at a low dose; it's contraindicated in severe cases.
What if you forget to take Glimefest Trio 2mg/500mg/0.3mg Tablet :
Should you forget to take your Glimefest Trio 2mg/500mg/0.3mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimefest Trio 2mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Category | Diabetes medication |
3,018 People bought this recently